title: Combining carbamazepine, neuroleptics and acetylcholinesterase inhibitors with methylphenidate only reduces adverse side effects, but is less effective than a combination with atomoxetine.
authors.forename: H
authors.initials: H
authors.lastname: Niederhofer
mesh_terms: D000374:Aggression; D014150:Antipsychotic Agents / Q000008:administration & dosage*; D000069445:Atomoxetine Hydrochloride; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D002220:Carbamazepine / Q000008:administration & dosage*; D002648:Child; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D004357:Drug Synergism; D006801:Humans; D008297:Male; D008774:Methylphenidate / Q000008:administration & dosage*; D011437:Propylamines / Q000008:administration & dosage*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D002800:Cholinesterase Inhibitors; D011437:Propylamines; D008774:Methylphenidate; D002220:Carbamazepine; D000069445:Atomoxetine Hydrochloride